Phenotypic differences during the osteogenic differentiation of single cell-derived clones isolated from human lipoaspirates

Abstract

Osteogenic precursors can be obtained from mesenchymal stem cells, which can be isolated from different sources, including adipose tissue. Optimal osteogenic differentiation in in vitro conditions and the selection of the potential precursors that could be further used in bone regeneration still have two main questions left to solve, viz. the heterogeneity of the mesenchymal cell population and the presence of a basal transcription level of several characteristic genes of the osteogenic lineage, which makes rapid and effective comparisons during cell differentiation difficult. Single-cell clones were isolated and expanded from human lipoaspirate cells. Osteogenic differentiation was induced and studied in defined media, using four representative isolated cell clones showing differences in the basal expression of a set of characteristic osteogenic genes. The clones showing a low constitutive expression of these genes were able to display comparatively higher levels of mineralization. In addition, the cells from these clones displayed a characteristic pattern of bundle fibres of collagen during osteogenic induction and showed a higher potency to differentiate towards the adipogenic lineage. These results demonstrate that specific multipotent precursors can be isolated from human lipoaspirate cells with a higher differentiation potential, allowing the maturation of specific lineages in a shorter time. These results additionally demonstrate that, since the basal expressions of the several genes were used as osteogenic markers, a phenotypic biochemical analysis should always be utilized to study optimal osteogenesis conditions. Copyright © 2010 John Wiley & Sons, Ltd.

Human Perivascular Stem Cell-Based Bone Graft Substitute Induces Rat Spinal Fusion

“…com). However, SVF is well recognized to be a heterogeneous population including nonstem cells, such as inflammatory, hematopoietic, and endothelial cells, which results in unreliable bone formation [22][23][24]. With these drawbacks of currently available MSC sources, there exists a clinical need for a reliable source of MSC with proven safety, purity, identity, and efficacy.…”

Human Perivascular Stem Cells Show Enhanced Osteogenesis and Vasculogenesis with Nel-Like Molecule I Protein

“…11 Moreover, SVF is a heterogeneous cell population that contains numerous nonstem cell types, such as inflammatory cells, hematopoietic cells, and endothelial cells, among others. [12][13][14] Heterogeneity complicates characterization of cell composition and introduces variability across samples. Such inconsistencies hamper efforts toward a reliable and standardized cell-based therapeutic for bone regeneration.…”

Cell and organ bioengineering technology as applied to gastrointestinal diseases

“…Recent research highlights the promise of chemically induced, stepwise protocols that make use of MSCs from the umbilical cord blood107 and neural crest-derived tissues108 such as the periodontal ligament109 or the eyelid fat,110 among other sources. However, the quest for a gold standard of differentiation (similar to that represented by the Viacyte protocol for the field of human ES cells)88 90 has been hindered by the observation that even individual MSC clones from the same tissue display variability in their differentiation potential 111. Also, for MSCs to give rise to functional insulin-producing cells, they have to surmount an obstacle that pluripotent cells do not—namely, their inherent commitment along the mesodermal lineage.…”